Search Results for: Bristol-Myers Squibb
Bristol Myers Squibb to Invest $40 Billion in U.S. Research and Manufacturing Over Five Years
2025-05-06
STAT Reporters Analyze Pharma Tariffs, Biotech Stock Rebound, and Bristol Myers Squibb Drug Trial Setback
2025-04-24
STAT Reporters Discuss: Bristol Myers Squibb Drug Data Disappoints Amid Pharmaceutical Tariff Concerns and Biotech Stock Recovery
2025-04-24
Bristol Myers Squibb Schizophrenia Drug Fails Pivotal Test as an Add-On to Antipsychotics
2025-04-24
Bristol Myers Squibb’s Schizophrenia Drug Fails to Show Added Benefit in Conjunction with Standard Treatment
2025-04-22
Bristol Myers Squibb Schizophrenia Drug Fails to Show Added Benefit in Trial as Adjunct Therapy
2025-04-22
HoneyBear Biosciences Gets Gold: First to Publish ARC Research in Asia & Wins ‘Best ADC Developer in Taiwan’ at 2025 ABEA
2025-03-13
Gensaic Partners with Novo Nordisk in $354M Deal to Advance Precision Therapies for Cardiometabolic Diseases
2025-03-04
